Teachers Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Teachers Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$2.63M	Buy	157,463 +136,645	+656%	+$1.97M	﹤0.01%	1807
2018 Q4	$239K	Buy	20,818 +3,538	+20%	+$71.6K	﹤0.01%	2793
2018 Q3	$691K	Sell	17,280 -185	-1%	-$5.26K	﹤0.01%	2499
2018 Q2	$494K	Buy	+17,465	New	+$387K	﹤0.01%	2657

Other funds holding MRNS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Teachers Advisors's MRNS Position: Q1 2019 in Review

Teachers Advisors increased its Marinus Pharmaceuticals, Inc (MRNS) stake by 656% in Q1 2019, buying an estimated $1.97M and bringing the position to 157,463 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Teachers Advisors first reported a position in MRNS in Q2 2018 and has held it in 4 quarters since. 81 funds tracked by Wall St. Rank hold MRNS as of Q1 2019.

Teachers Advisors held 157,463 shares of Marinus Pharmaceuticals, Inc worth $2.63M as of Q1 2019.
Teachers Advisors bought 136,645 Marinus Pharmaceuticals, Inc shares in Q1 2019, an estimated $1.97M.
Marinus Pharmaceuticals, Inc made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1807 holding.
Teachers Advisors first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and has held it in 4 quarters since.
81 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.